Handelen CareDx, Inc - CDNA CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.08 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
CareDx Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 21.9 |
| Open* | 21.64 |
| 1-Jaarlijkse Verandering* | -1.95% |
| Dagelijks bereik* | 21.56 - 22.33 |
| 52 wekelijks bereik | 6.22-27.35 |
| Weekgemiddelde volume (10 dagen) | 602.70K |
| Gemiddeld volume (3 maanden) | 18.28M |
| Marktkapitalisatie | 454.55M |
| P/E Ratio | -100.00K |
| Uitstaande Aandelen | 53.79M |
| Omzet | 319.64M |
| EPS | -1.51 |
| Dividend (opbrengst %) | N/A |
| Beta | 1.01 |
| Volgende inkomsten datum | Aug 2, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 22.04 | 0.56 | 2.61% | 21.48 | 22.36 | 21.37 |
| Jun 28, 2022 | 21.90 | -1.15 | -4.99% | 23.05 | 23.76 | 21.78 |
| Jun 27, 2022 | 23.46 | -0.24 | -1.01% | 23.70 | 23.82 | 22.83 |
| Jun 24, 2022 | 23.63 | -0.31 | -1.29% | 23.94 | 24.59 | 23.05 |
| Jun 23, 2022 | 23.97 | 1.91 | 8.66% | 22.06 | 24.07 | 21.95 |
| Jun 22, 2022 | 21.78 | 1.80 | 9.01% | 19.98 | 22.43 | 19.97 |
| Jun 21, 2022 | 20.61 | -0.13 | -0.63% | 20.74 | 21.48 | 20.56 |
| Jun 17, 2022 | 20.47 | -0.10 | -0.49% | 20.57 | 21.55 | 20.22 |
| Jun 16, 2022 | 20.52 | 0.58 | 2.91% | 19.94 | 20.78 | 19.92 |
| Jun 15, 2022 | 21.03 | 0.39 | 1.89% | 20.64 | 21.70 | 20.42 |
| Jun 14, 2022 | 20.61 | -0.13 | -0.63% | 20.74 | 20.77 | 19.29 |
| Jun 13, 2022 | 20.46 | -0.96 | -4.48% | 21.42 | 22.47 | 20.25 |
| Jun 10, 2022 | 22.69 | -0.83 | -3.53% | 23.52 | 23.97 | 22.22 |
| Jun 9, 2022 | 24.35 | -1.13 | -4.43% | 25.48 | 25.99 | 24.24 |
| Jun 8, 2022 | 26.41 | 0.53 | 2.05% | 25.88 | 27.30 | 25.49 |
| Jun 7, 2022 | 26.18 | 2.73 | 11.64% | 23.45 | 26.28 | 23.45 |
| Jun 6, 2022 | 24.25 | -1.99 | -7.58% | 26.24 | 26.79 | 24.12 |
| Jun 3, 2022 | 25.84 | -0.13 | -0.50% | 25.97 | 26.43 | 25.34 |
| Jun 2, 2022 | 26.41 | 1.10 | 4.35% | 25.31 | 27.09 | 24.96 |
| Jun 1, 2022 | 25.36 | 0.22 | 0.88% | 25.14 | 25.89 | 24.97 |
CareDx, Inc Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Tuesday, June 13, 2023 | ||
| Tijd (UTC) (UTC) 23:40 | Land US
| Evenement CareDx Inc at Goldman Sachs Healthcare Conference CareDx Inc at Goldman Sachs Healthcare ConferenceForecast -Previous - |
| Thursday, June 15, 2023 | ||
| Tijd (UTC) (UTC) 17:00 | Land US
| Evenement CareDx Inc Annual Shareholders Meeting CareDx Inc Annual Shareholders MeetingForecast -Previous - |
| Tijd (UTC) (UTC) 17:00 | Land US
| Evenement CareDx Inc Annual Shareholders Meeting CareDx Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 2, 2023 | ||
| Tijd (UTC) (UTC) 10:59 | Land US
| Evenement Q2 2023 CareDx Inc Earnings Release Q2 2023 CareDx Inc Earnings ReleaseForecast -Previous - |
| Wednesday, November 1, 2023 | ||
| Tijd (UTC) (UTC) 10:59 | Land US
| Evenement Q3 2023 CareDx Inc Earnings Release Q3 2023 CareDx Inc Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 321.793 | 296.397 | 192.194 | 127.068 | 76.569 |
| Inkomsten | 321.793 | 296.397 | 192.194 | 127.068 | 76.569 |
| Kosten van opbrengsten, totaal | 112.212 | 97.389 | 63.117 | 45.455 | 32.987 |
| Brutowinst | 209.581 | 199.008 | 129.077 | 81.613 | 43.582 |
| Totale bedrijfskosten | 399.024 | 326.123 | 209.909 | 151.6 | 97.927 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 194.172 | 150.309 | 102.664 | 75.434 | 43.629 |
| Onderzoek & Ontwikkeling | 90.388 | 76.525 | 48.941 | 30.711 | 14.514 |
| Ongebruikelijke uitgaven (inkomsten) | 0 | 0 | -4.813 | 0 | 5.78 |
| Other Operating Expenses, Total | 1.017 | ||||
| Bedrijfsresultaat | -77.231 | -29.726 | -17.715 | -24.532 | -21.358 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 3.869 | 0.266 | -1.224 | 1.304 | -26.679 |
| Overige, Netto | -2.872 | -2.628 | -0.811 | -0.719 | -0.178 |
| Netto inkomen voor belastingen | -76.234 | -32.088 | -19.75 | -23.947 | -48.215 |
| Netto inkomen na belastingen | -76.613 | -30.662 | -18.714 | -21.968 | -46.781 |
| Minderheidsbelang | 0 | 0 | 0.025 | ||
| Netto inkomen voor extra. Posten | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 |
| Netto inkomen | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 |
| Verwaterd Netto Inkomen | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 |
| Verwaterd Gewogen Gemiddelde Aandelen | 53.3216 | 52.2411 | 46.4818 | 42.1516 | 35.639 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -1.43681 | -0.58693 | -0.40261 | -0.52117 | -1.31194 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Verwaterde Genormaliseerde Winst per Aandeel | -1.43681 | -0.58693 | -0.46991 | -0.52117 | -1.20652 |
| Totale buitengewone posten | |||||
| Depreciation / Amortization | 2.252 | 1.9 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 77.262 | 82.384 | 79.359 | 80.634 | 79.416 |
| Inkomsten | 77.262 | 82.384 | 79.359 | 80.634 | 79.416 |
| Kosten van opbrengsten, totaal | 25.966 | 29.49 | 28.301 | 27.539 | 26.882 |
| Brutowinst | 51.296 | 52.894 | 51.058 | 53.095 | 52.534 |
| Totale bedrijfskosten | 101.586 | 101.504 | 96.698 | 102.353 | 98.469 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 50.268 | 47.894 | 45.537 | 51.639 | 49.107 |
| Onderzoek & Ontwikkeling | 24.357 | 23.57 | 22.306 | 22.632 | 21.88 |
| Depreciation / Amortization | 0.595 | 0.55 | 0.554 | 0.543 | 0.6 |
| Bedrijfsresultaat | -24.324 | -19.12 | -17.339 | -21.719 | -19.053 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 2.673 | 1.888 | 1.239 | 0.526 | 0.216 |
| Overige, Netto | -1.974 | -0.924 | -0.572 | -0.553 | -0.823 |
| Netto inkomen voor belastingen | -23.625 | -18.156 | -16.672 | -21.746 | -19.66 |
| Netto inkomen na belastingen | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Netto inkomen voor extra. Posten | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Netto inkomen | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Verwaterd Netto Inkomen | -23.749 | -18.329 | -16.939 | -21.697 | -19.648 |
| Verwaterd Gewogen Gemiddelde Aandelen | 53.6432 | 53.5269 | 53.4894 | 53.2495 | 53.0155 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.44272 | -0.34243 | -0.31668 | -0.40746 | -0.37061 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.43787 | -0.34243 | -0.31668 | -0.40746 | -0.37061 |
| Ongebruikelijke uitgaven (inkomsten) | 0.4 | 0 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 387.849 | 433.36 | 273.097 | 71.922 | 81.114 |
| Geldmiddelen en kortetermijnbeleggingen | 293.089 | 348.485 | 224.703 | 38.223 | 64.616 |
| Geldmiddelen & Equivalenten | 89.921 | 348.485 | 134.669 | 38.223 | 64.616 |
| Totale Vorderingen, Netto | 66.312 | 59.761 | 34.624 | 24.057 | 9.76 |
| Accounts Receivable - Trade, Net | 66.312 | 59.761 | 34.624 | 24.057 | 9.76 |
| Total Inventory | 19.232 | 17.186 | 10.012 | 6.014 | 4.943 |
| Prepaid Expenses | 9.216 | 7.928 | 3.758 | 3.628 | 1.795 |
| Total Assets | 542.991 | 566.621 | 368.511 | 151.736 | 130.697 |
| Property/Plant/Equipment, Total - Net | 70.218 | 40.037 | 25.932 | 9.16 | 4.134 |
| Goodwill, Net | 37.523 | 36.983 | 23.857 | 23.857 | 12.005 |
| Intangibles, Net | 43.051 | 50.195 | 44.355 | 45.541 | 33.252 |
| Other Long Term Assets, Total | 4.35 | 6.046 | 1.27 | 1.256 | 0.192 |
| Total Current Liabilities | 75.975 | 77.301 | 69.217 | 34.828 | 19.504 |
| Accounts Payable | 9.942 | 13.337 | 9.653 | 5.506 | 4.711 |
| Accrued Expenses | 40.599 | 43.792 | 25.58 | 18.825 | 11.246 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.071 | 0.172 | |||
| Other Current Liabilities, Total | 25.434 | 20.172 | 33.913 | 10.497 | 3.375 |
| Total Liabilities | 112.08 | 100.745 | 90.832 | 52.736 | 34.769 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | 0 | ||||
| Deferred Income Tax | 0 | 0.415 | 1.299 | 1.973 | 2.968 |
| Minority Interest | 0 | ||||
| Other Liabilities, Total | 36.105 | 23.029 | 20.316 | 15.935 | 12.297 |
| Total Equity | 430.911 | 465.876 | 277.679 | 99 | 95.928 |
| Common Stock | 0.052 | 0.052 | 0.049 | 0.042 | 0.041 |
| Additional Paid-In Capital | 898.806 | 853.683 | 632.253 | 437.976 | 412.01 |
| Retained Earnings (Accumulated Deficit) | -460.444 | -383.189 | -352.527 | -333.813 | -311.845 |
| Other Equity, Total | -7.503 | -4.67 | -2.096 | -5.205 | -4.278 |
| Total Liabilities & Shareholders’ Equity | 542.991 | 566.621 | 368.511 | 151.736 | 130.697 |
| Total Common Shares Outstanding | 53.5332 | 52.9234 | 49.4412 | 42.4984 | 41.385 |
| Redeemable Preferred Stock | 0 | ||||
| Property/Plant/Equipment, Total - Gross | 94.642 | 59.618 | 42.931 | 24.253 | 18.234 |
| Accumulated Depreciation, Total | -24.424 | -19.581 | -16.999 | -15.093 | -14.1 |
| Korte Termijn Investeringen | 203.168 | 0 | 90.034 | ||
| Capital Lease Obligations | 0 | ||||
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 371.428 | 387.849 | 388.157 | 403.88 | 411.487 |
| Geldmiddelen en kortetermijnbeleggingen | 285.939 | 293.089 | 291.276 | 306.22 | 319.222 |
| Geldmiddelen & Equivalenten | 74.66 | 89.921 | 82.959 | 166.832 | 171.892 |
| Korte Termijn Investeringen | 211.279 | 203.168 | 208.317 | 139.388 | 147.33 |
| Totale Vorderingen, Netto | 59.31 | 66.312 | 70.425 | 70.142 | 65.32 |
| Accounts Receivable - Trade, Net | 59.31 | 66.312 | 70.425 | 70.142 | 65.32 |
| Total Inventory | 18.018 | 19.232 | 18.086 | 18.861 | 18.212 |
| Prepaid Expenses | 8.161 | 9.216 | 8.37 | 8.657 | 8.733 |
| Total Assets | 528.217 | 542.991 | 544.511 | 541.288 | 546.711 |
| Property/Plant/Equipment, Total - Net | 68.937 | 70.218 | 69.892 | 48.745 | 44.686 |
| Goodwill, Net | 39.615 | 37.523 | 37.523 | 37.084 | 36.983 |
| Intangibles, Net | 45.637 | 43.051 | 43.855 | 46.318 | 48.149 |
| Other Long Term Assets, Total | 2.6 | 4.35 | 5.084 | 5.261 | 5.406 |
| Total Current Liabilities | 71.828 | 75.975 | 70.288 | 78.456 | 66.92 |
| Accounts Payable | 12.861 | 9.942 | 10.625 | 16.892 | 10.605 |
| Accrued Expenses | 34.017 | 40.599 | 35.078 | 35.86 | 33.455 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Other Current Liabilities, Total | 24.95 | 25.434 | 24.585 | 25.704 | 22.86 |
| Total Liabilities | 108.196 | 112.08 | 107.832 | 97.739 | 89.167 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | |||||
| Deferred Income Tax | 0 | 0.013 | 0.025 | 0.194 | |
| Other Liabilities, Total | 36.368 | 36.105 | 37.531 | 19.258 | 22.053 |
| Total Equity | 420.021 | 430.911 | 436.679 | 443.549 | 457.544 |
| Preferred Stock - Non Redeemable, Net | 0 | ||||
| Common Stock | 0.052 | 0.052 | 0.052 | 0.052 | 0.052 |
| Additional Paid-In Capital | 912.291 | 898.806 | 886.909 | 875.213 | 865.419 |
| Retained Earnings (Accumulated Deficit) | -484.883 | -460.444 | -441.473 | -424.534 | -402.837 |
| Other Equity, Total | -7.439 | -7.503 | -8.809 | -7.182 | -5.09 |
| Total Liabilities & Shareholders’ Equity | 528.217 | 542.991 | 544.511 | 541.288 | 546.711 |
| Total Common Shares Outstanding | 53.6532 | 53.5332 | 53.5234 | 53.3237 | 53.0853 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -76.613 | -30.662 | -18.714 | -21.968 | -46.781 |
| Geldmiddelen uit Operationele Activiteiten | -25.239 | -19.294 | 33.431 | -2.769 | -4.007 |
| Geldmiddelen uit Operationele Activiteiten | 11.595 | 8.797 | 7.006 | 5.523 | 4.215 |
| Deferred Taxes | -0.215 | -1.379 | -1.023 | -1.28 | -1.607 |
| Niet-Geldelijke Posten | 53.996 | 43.541 | 27.743 | 24.089 | 39.43 |
| Contant Betaalde Rente | 0.008 | 0.001 | 0.01 | 0.022 | 1.774 |
| Veranderingen in het Operationeel Kapitaal | -14.002 | -39.591 | 18.419 | -9.133 | 0.736 |
| Geldmiddelen uit Investeringsactiviteiten | -228.502 | 47.712 | -100.394 | -22.579 | -7.929 |
| Kapitaaluitgaven | -24.334 | -20.259 | -10.36 | -3.349 | -7.237 |
| Overige Cash Flow investeringsposten, Totaal | -204.168 | 67.971 | -90.034 | -19.23 | -0.692 |
| Geldmiddelen uit Financieringsactiviteiten | -4.535 | 185.642 | 163.149 | -0.132 | 50.268 |
| Financiering van Cash Flow Posten | -8.558 | -18.065 | -4.529 | -4.378 | -0.923 |
| Uitgifte (Aflossing) van aandelen, netto | 4.023 | 203.773 | 167.861 | 4.418 | 65.675 |
| Uitgifte (Aflossing) van Schulden, Netto | 0 | -0.066 | -0.183 | -0.172 | -14.484 |
| Wisselkoerseffecten | 0.023 | -0.303 | 0.274 | -0.849 | 0.002 |
| Nettowijziging in Geldmiddelen | -258.253 | 213.757 | 96.46 | -26.329 | 38.334 |
| Cash Taxes Paid | 0.392 | 0.014 | 0.08 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -23.749 | -76.613 | -58.284 | -41.345 | -19.648 |
| Cash From Operating Activities | 0.671 | -25.239 | -32.424 | -25.345 | -21.468 |
| Cash From Operating Activities | 3.427 | 11.595 | 8.389 | 5.363 | 2.619 |
| Deferred Taxes | 0 | -0.215 | -0.157 | -0.158 | -0.217 |
| Non-Cash Items | 16.58 | 53.996 | 40.336 | 26.564 | 12.232 |
| Changes in Working Capital | 4.413 | -14.002 | -22.708 | -15.769 | -16.454 |
| Cash From Investing Activities | -14.771 | -228.502 | -230.977 | -155.242 | -156.032 |
| Capital Expenditures | -2.771 | -24.334 | -21.057 | -15.211 | -8.563 |
| Other Investing Cash Flow Items, Total | -12 | -204.168 | -209.92 | -140.031 | -147.469 |
| Cash From Financing Activities | -1.138 | -4.535 | -2.163 | -1.132 | 0.865 |
| Financing Cash Flow Items | -0.906 | -8.558 | -6.543 | -4.142 | -1.732 |
| Issuance (Retirement) of Stock, Net | -0.232 | 4.023 | 4.38 | 3.01 | 2.597 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
| Foreign Exchange Effects | -0.025 | 0.023 | 0.025 | 0.059 | 0.045 |
| Net Change in Cash | -15.263 | -258.253 | -265.539 | -181.66 | -176.59 |
| Cash Interest Paid |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| ARK Investment Management LLC | Investment Advisor | 12.64 | 6799439 | 611257 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.6002 | 5164236 | -97614 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 9.0681 | 4878036 | -869208 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.6611 | 3583185 | -66249 | 2023-03-31 | LOW |
| Bellevue Asset Management AG | Investment Advisor | 6.3932 | 3439091 | 270643 | 2023-03-31 | LOW |
| Armistice Capital LLC | Hedge Fund | 5.8297 | 3136000 | 2636000 | 2023-03-31 | HIGH |
| Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 5.1131 | 2750468 | 187308 | 2023-03-31 | LOW |
| D. E. Shaw & Co., L.P. | Hedge Fund | 3.7821 | 2034528 | 628715 | 2023-03-31 | LOW |
| Gagnon Securities LLC | Investment Advisor/Hedge Fund | 3.7436 | 2013813 | 518067 | 2023-03-31 | LOW |
| Millennium Management LLC | Hedge Fund | 3.1599 | 1699800 | 988259 | 2023-03-31 | HIGH |
| Assenagon Asset Management S.A. | Investment Advisor | 2.1645 | 1164368 | 985010 | 2023-03-31 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 1.909 | 1026900 | 81200 | 2023-03-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8897 | 1016530 | 34511 | 2023-03-31 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 1.8724 | 1007244 | 742169 | 2023-03-31 | MED |
| Two Sigma Investments, LP | Hedge Fund | 1.403 | 754704 | 14751 | 2023-03-31 | HIGH |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.1884 | 639257 | 639257 | 2023-03-31 | HIGH |
| Voloridge Investment Management, LLC | Investment Advisor/Hedge Fund | 1.157 | 622369 | 105536 | 2023-03-31 | HIGH |
| Gagnon Advisors, LLC | Hedge Fund | 0.978 | 526088 | 87681 | 2023-03-31 | LOW |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9729 | 523367 | 251692 | 2023-03-31 | LOW |
| BofA Global Research (US) | Research Firm | 0.9492 | 510603 | -4013 | 2023-03-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group535K+
Handelaren
87K+
Actieve klanten per maand
$113M+
Maandelijks beleggingsvolume
$64M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
CareDx, Inc Company profile
Over CareDx, Inc
CareDx, Inc. is een bedrijf gespecialiseerd in precisiegeneeskunde. Het bedrijf richt zich op de ontdekking, ontwikkeling en commercialisering van klinisch gedifferentieerde diagnostische oplossingen voor transplantatiepatiënten en zorgverleners. Het biedt testdiensten, producten en digitale oplossingen voor het traject dat patiënten afleggen voor en na een transplantatie en is een leverancier van op genomica gebaseerde informatie voor transplantatiepatiënten. De commercieel beschikbare testdiensten van het bedrijf bestaan uit AlloSure Kidney, een oplossing van donorafhankelijk celvrij DNA (dd-cfDNA) voor niertransplantatiepatiënten, AlloMap Heart, een oplossing van genexpressie voor harttransplantatiepatiënten, en AlloSure Heart, een dd-cf-DNA-oplossing voor harttransplantatiepatiënten. De reeks AlloSeq-producten omvat: AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP en QTYPE. Het bedrijf levert ook software voor het traceren van transplantatiepatiënten, Ottr-software, en oplossingen voor het traceren van transplantatiekwaliteit en wachtlijstbeheer.
| Industry: | Bio Diagnostics & Testing |
8000 Marina Blvd
4Th Floor
BRISBANE
CALIFORNIA 94005
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 535.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen